Ignite Creation Date:
2024-05-06 @ 7:59 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06202131
Status:
RECRUITING
Last Update Posted:
2024-01-11
First Post:
2024-01-02
Brief Title:
Prospective Single-center Study About the Use of ctDNA in the Management of Patients With Tumors of the Gastrointestinal Tract
Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Organization:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Study Overview
Official Title:
Prospective Single-center Study About the Use of ctDNA in the Management of Patients With Tumors of the Gastrointestinal Tract
Status:
RECRUITING
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ctDNA-GI
Brief Summary:
This study will evaluate the use of ctDNA in the clinical management of patients with tumors of the gastrointestinal tract
Detailed Description:
This is a a prospective observational single-center study it is a spontaneous study not sponsored by pharmaceutical companies and does not involve the use of experimental drugs The study involves a collection of data carried out while protecting the anonymity and personal information of individual patients suffering from neoplasms of the gastrointestinal tract the execution of peripheral blood samples and the collection of faecal material at pre-determined times -points Circulating biomarkers as ctDNA will be evaluated in these samples in order to optimize both the diagnostic and therapeutic processes of patients with tumors of the gastrointestinal tract
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None